FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * MYERS ROBERT L 2. Issuer Name and Ticker or Trading Symbol Predictive Oncology Inc. [ POAI ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
CHIEF FINANCIAL OFFICER
(Last)          (First)          (Middle)
2915 COMMERS DRIVE, SUITE 900
3. Date of Earliest Transaction (MM/DD/YYYY)
9/23/2022
(Street)
EAGAN, MN 55121
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  9/23/2022    M(1)    33333  A  (2) 72669  D 
 
Common Stock  9/23/2022    F(3)    10199  D $.3949  62470  D 
 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units   (2) 9/23/2022    M        33333    (1)  (1)(2) Common Stock  33333  $0  33333  D 
 

Explanation of Responses:
(1)  On September 23, 2020, the reporting person was granted 100,000 restricted stock units, vesting in three annual installments on each of September 23, 2021, September 23, 2022 and September 23, 2023.
(2)  Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock. The shares are delivered to the Reporting Person upon vesting.
(3)  10,199 shares of common stock forfeited to Company on September 23, 2022 to cover withholding tax, in accordance with Restricted Stock Unit Agreement between Reporting Person and Company.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
MYERS ROBERT L
2915 COMMERS DRIVE, SUITE 900
EAGAN, MN 55121


CHIEF FINANCIAL OFFICER

Signatures
/s/ Bob Myers 9/27/2022
**Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Predictive Oncology (NASDAQ:POAI)
Historical Stock Chart
From Oct 2022 to Nov 2022 Click Here for more Predictive Oncology Charts.
Predictive Oncology (NASDAQ:POAI)
Historical Stock Chart
From Nov 2021 to Nov 2022 Click Here for more Predictive Oncology Charts.